HYFT
ImmunoPrecise Antibodies Ltd.
1.30$
-4.0%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +7.5% | +38.7% | +106.9% | +100.8% | +34.7% | +21.7% | +8.1% | +6.7% | +18.6% | +0.0% | -37.5% | |
| – | -21.0% | +146,876.6% | +147.2% | +88.3% | +171.6% | -58.3% | +31.5% | +8.6% | +36.9% | -12.0% | -42.5% | |
| – | – | – | +72.5% | +116.0% | -110.9% | – | -4.8% | +5.3% | +4.2% | +12.4% | -33.5% | |
| – | -51.3% | +118.1% | -22.9% | -4.6% | -3.8% | +322.4% | +288.2% | +84.0% | -71.3% | +22.3% | -1.7% | |
| – | +1,438.2% | +86.2% | +205.0% | +29.4% | +8.5% | +58.2% | +22.3% | +0.0% | +1.4% | -5.5% | +30.0% | |
| – | +2,444.2% | +69.8% | +162.9% | +56.1% | -67.8% | +323.4% | +76.0% | +34.4% | -30.6% | -0.3% | -7.9% | |
| – | – | -671.4% | – | – | – | – | – | – | – | – | – | |
| – | -23.3% | +6,354.2% | +402.1% | +919.1% | -14.2% | -18.2% | -85.9% | -64.7% | -36.7% | -47.8% | -100.0% | |
| – | – | -2,352.7% | – | – | – | – | – | – | – | – | – | |
| – | +27,003.8% | -189.9% | – | -95.6% | -7,660.7% | – | -36.0% | -238.4% | – | – | – | |
| – | – | -3,664.6% | – | – | – | – | – | – | – | – | – | |
| – | – | -1,937.6% | – | – | – | – | – | – | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.